Skip to Main Content

Paper Details

Locoregional tumor burden and risk of mortality in metastatic breast cancer.
NPJ Precis Oncol
3
2022
HER2, HR, breast cancer, breast tumors, hormone receptor, hormone receptor (HR)-positive/HER2-negative, metastatic, metastatic breast cancer, metastatic disease, patients, triple-negative metastatic breast cancer, tumor
Author NameAffiliation
Stephen M HewittCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Stephen M HewittCenter for Cancer Research, National Cancer Institute, National Institutes of Health
  • 1 - 2

Datasets

Release 1.2